Video from AACC: Enzo BioChem CEO on COVID-19 test landscape

By Leo O'Connor, Editor in Chief
August 1, 2022

Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the in vitro diagnostics (IVD) landscape as the COVID-19 pandemic evolves.

Enzo BioChem develops diagnostic tests and provides testing in centers throughout New York and its surrounding areas. CEO Hamid Erfanian spoke to us at AACC 2022 about the changes he sees in the IVD landscape as the COVID-19 pandemic evolves.

Click on the video below for the interview.

Hamid Erfanian AACC interview

Enzo BioChem CEO Hamid Erfanian.

If you like this content, please share it with a colleague!

Related Reading

Video from AACC: Beckman Coulter partners with Scopio
Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood...

Video from AACC: AACC president on Theranos, VALID Act
Dr. Stephen Master, president of the American Association for Clinical Chemistry, provided his thoughts about the main highlights of the 2022 AACC Annual...

Video from AACC: Cytovale immune-response test for sepsis
Cytovale CEO Ajay Shah discusses unmet needs in the sepsis testing market and the firm’s 10-minute direct-from-blood IntelliSep test.

Video from AACC: Thermo Fisher CMO on the future of diagnostics
Thermo Fisher Scientific featured a broad array of diagnostic testing products at AACC 2022. Chief Medical Officer (CMO) Manoj Gandhi caught up with ScienceBoard.net's...

Video from AACC: Reducing sequencing complexity
Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net)...